- Home
- IDXX vs ALC Comparison
IDXX vs ALC Comparison
Compare IDXX & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDXX
- ALC
- Stock Information
- Founded
- IDXX 1983
- ALC 1945
- Country
- IDXX United States
- ALC Switzerland
- Employees
- IDXX N/A
- ALC N/A
- Industry
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ALC Ophthalmic Goods
- Sector
- IDXX Health Care
- ALC Health Care
- Exchange
- IDXX Nasdaq
- ALC Nasdaq
- Market Cap
- IDXX 42.7B
- ALC 43.0B
- IPO Year
- IDXX 1991
- ALC N/A
- Fundamental
- Price
- IDXX $547.01
- ALC $87.91
- Analyst Decision
- IDXX Buy
- ALC Buy
- Analyst Count
- IDXX 8
- ALC 10
- Target Price
- IDXX $542.25
- ALC $107.00
- AVG Volume (30 Days)
- IDXX 468.2K
- ALC 1.5M
- Earning Date
- IDXX 08-04-2025
- ALC 08-19-2025
- Dividend Yield
- IDXX N/A
- ALC 0.25%
- EPS Growth
- IDXX 4.80
- ALC 6.66
- EPS
- IDXX 10.82
- ALC 2.25
- Revenue
- IDXX $3,931,836,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- IDXX $8.27
- ALC $6.22
- Revenue Next Year
- IDXX $7.73
- ALC $7.16
- P/E Ratio
- IDXX $50.58
- ALC $38.98
- Revenue Growth
- IDXX 5.56
- ALC 3.80
- 52 Week Low
- IDXX $356.14
- ALC $80.48
- 52 Week High
- IDXX $548.54
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- IDXX 72.15
- ALC 49.95
- Support Level
- IDXX $524.65
- ALC $86.94
- Resistance Level
- IDXX $546.39
- ALC $89.52
- Average True Range (ATR)
- IDXX 9.52
- ALC 1.29
- MACD
- IDXX 0.28
- ALC 0.42
- Stochastic Oscillator
- IDXX 95.58
- ALC 66.34
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.